Drug Shortage Report for IRINOTECAN HYDROCHLORIDE INJECTION USP
Report ID | 3252 |
Drug Identification Number | 02357585 |
Brand name | IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION |
Common or Proper name | IRINOTECAN |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | IRINOTECAN HYDROCHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5 ML VIAL OF 100 MG | FLACON DE 5 ML DE 100 MG |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2016-12-27 |
Actual start date | 2016-12-27 |
Estimated end date | 2017-03-22 |
Actual end date | 2017-03-22 |
Shortage status | Resolved |
Updated date | 2017-03-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-04-06 | French | Compare |
v5 | 2017-03-23 | French | Compare |
v4 | 2017-03-23 | English | Compare |
v3 | 2017-03-17 | French | Compare |
v2 | 2017-03-17 | English | Compare |
v1 | 2017-03-17 | English | Compare |
Showing 1 to 6 of 6